Biotalys Provides Update on Its Plans to Fund Next Phase of DevelopmentGhent, BELGIUM, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Press release – inside information* Biotalys (Euronext: BTLS) and 21st.BIO, a ...
Princeton-based Amicus has a gene therapy research center in Philadelphia. The transaction didn't come together until after ...
A new Ember report finds India is electrifying its economy faster than China did at a similar income level, while using far ...
Author and visual artist Robert Burleigh, widely acclaimed for his poetic picture book nonfiction and biographies of such ...
"We are grateful for the collaborative feedback from FDA on the Gemini program, which provides us a clear and expedient path forward for seeking approval of Gemini as a treatment for AKI," said, James ...
BASF announced today its participation in PlastIndia 2026, scheduled to take place from February 5 to 10, 2026 in New Delhi, ...
Vietnam will officially transition to the use of E5 and E10 biofuels from June 1, 2026 in line with a roadmap prepared over ...
These tags add menus, toggles, media, forms, and responsive images with minimal code.
TikTok has become the top source for mental health terminology, as cost keeps many Americans from accessing traditional ...
Wikipedia had to fight to establish its legitimacy—and now it faces a new existential threat posed by generative AI ...
Unlike traditional transplant approaches, the goal is not to permanently replace a failing liver, but to create a temporary, ...
Oxford Biomedica's estimated fair value is UK£15.28 based on 2 Stage Free Cash Flow to Equity Current share price of UK£8.04 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback